experimental group:avatrombopag

2 trials

Sponsors

Zhejiang Provincial Hospital of Traditional Chinese Medicine, The Forth Affiliated Hospital Zhejiang University School of Medicine

Conditions

refractory chemotherapy induced thrombocytopeniathrombocytopenia with TPO or other TPORA ineffective

Early Phase 1

The novel effect of avatrombopag in the management of refractory chemotherapy induced thrombocytopenia (CIT) in patients with solid tumors: a single arm study

RecruitingChiCTR2100050646

Zhejiang Provincial Hospital of Traditional Chinese Medicinerefractory chemotherapy induced thrombocytopenia

Start: 2021-08-22Updated: 2022-05-02

A prospective, single-arm, exploratory study of avatrombopag in the treatment of thrombocytopenia with TPO or TPORA ineffective

Active, not recruitingChiCTR2200061853

The Forth Affiliated Hospital Zhejiang University School of Medicinethrombocytopenia with TPO or other TPORA ineffective

Start: 2022-06-20Updated: 2023-04-03

Related Papers

Efficiency and Safety of Avatrombopag in the Management of Thrombocytopenia with TPO or Tpora Ineffective：a Prospective, Single Arm, Exploratory Clinical Study

Blood2022-11-15

Effect of avatrombopag in the management of severe and refractory chemotherapy-induced thrombocytopenia (CIT) in patients with solid tumors

Platelets2022-01-1811 citations